Skip to main content
Log in

Potential inhibition of alkylating agent metabolism by fluconazole

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ninane J A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with haematological or oncological malignancies. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 330–337.

    Google Scholar 

  2. Morita K, Konishi H, Shimakawa H Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in mice and humans in vivo: comparative study with ketoconazole. Chemical and Pharmaceutical Bulletins 1992, 40: 127–1251.

    Google Scholar 

  3. Sugar AM, Saunders C, Idelson BA, Bernard DB Interaction of fluconazole and cyclosporine. Annals of Internal Medicine 1989, 110: 844.

    Google Scholar 

  4. Graves NM, Mantas AJ, Hilligoss DM, Cannafax DM Fluconazole-cyclosporine interaction. Clinical Pharmacology and Therapeutics 1990, 47: 208.

    Google Scholar 

  5. Kronbach T, Fischer V, Meyer UA Cyclosporine metabolism in human liver: identification of a cytochrome P-4503III gene family as the major cyclosporine-metabolising enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics 1988, 43: 630–635.

    PubMed  Google Scholar 

  6. Bienvenu T, Rey E, Pons G, D'Athis P, Oliver G A simple non-invasive procedure for the investigation of cytochrome P-450IIIA dependent enzymes in humans. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 1991, 29: 441–445.

    Google Scholar 

  7. Sladek NE Metabolism of oxazaphosphorines. Pharmacology and Therapeutics 1988, 37: 301–355.

    PubMed  Google Scholar 

  8. Chang TKH, Weber GF, Crespi CL, Waxman DJ Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Research 1993, 53: 5629–5637.

    PubMed  Google Scholar 

  9. Walker D, Flinois JP, Monkman SC, Beloc C, Boddy AV, Cholerton S, Daly AK, Lind MJ, Pearson ADJ, Beaune PH, Idle JR: Identification of the major human hepatic cytochrome P-450 involved in activation and N-dechlorethylation of ifosfamide. Biochemical Pharmacology 1994, 47: 1157–1163.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yule, S.M., Walker, D., Pearson, A.D.J. et al. Potential inhibition of alkylating agent metabolism by fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1086–1087 (1994). https://doi.org/10.1007/BF02111837

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111837

Keywords

Navigation